Wakefulness-Promoting AgentsReceptors, Adrenergic, alpha-2Receptors, AngiotensinAngiotensin IIAngiotensin Receptor AntagonistsReceptor, Angiotensin, Type 1Angiotensin II Type 1 Receptor BlockersReceptor, Angiotensin, Type 2Angiotensin ITetrazolesAngiotensin-Converting Enzyme InhibitorsLosartanAngiotensin IIIRenin-Angiotensin SystemBiphenyl CompoundsBenzimidazolesAntihypertensive AgentsAngiotensin II Type 2 Receptor BlockersAngiotensinsImidazolesHypertension1-Sarcosine-8-Isoleucine Angiotensin IIBlood PressureSaralasinValinePeptidyl-Dipeptidase AReninBenzoatesKidneyVasoconstrictor AgentsFumaratesRats, Sprague-DawleyLisinoprilDrug Therapy, CombinationPyridinesEnalaprilDiureticsDose-Response Relationship, DrugAldosteroneProteinuriaAngiotensinogenAmlodipineHeart FailureMineralocorticoid Receptor AntagonistsHydrochlorothiazidealpha 1-AntitrypsinRamipril3-Mercaptopropionic AcidRats, WistarReceptors, Adrenergic, alphaRats, Inbred SHRSpironolactoneDiet, Sodium-RestrictedAdrenergic beta-AntagonistsHyperkalemiaDiabetic NephropathiesAcrylatesMuscle, Smooth, VascularKidney DiseasesRNA, MessengerRats, Inbred WKYSignal TransductionVasoconstrictionMyocardiumTreatment OutcomeAmidesHypoxia-Inducible Factor 1, alpha SubunitEnalaprilatTime FactorsNorepinephrineCells, CulturedCardiovascular AgentsCalcium Channel BlockersDisease Models, AnimalHydralazineHypertension, RenalPeptide FragmentsRenal CirculationRandomized Controlled Trials as TopicBradykininMice, KnockoutAlbuminuriaCardiomegalyAortaAngiotensin AmideMice, Inbred C57BLGene Expression RegulationGlomerular Filtration Rate